Clinical Immunology Society (CIS) Annual Meeting
April 2022
- PATH4WARD: A Genetic Testing Program to Aid in Molecular Diagnosis of Congenital Neutropenia and Other Primary Immunodeficiencies Including WHIM Syndrome
- 4WHIM: Evaluating the Oral CXCR4 Antagonist Mavorixafor in Patients With WHIM Syndrome via a Global, Phase 3, Randomized, Placebo-Controlled Trial With Open-Label Extension